Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 258 to 307 of 8289 in total 
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
129\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen b1 (mage-b1 antigen) (mage-xp antigen) (dss-ahc critical interval mage superfamily 10) (dam10). [source:swissprot;acc:p43366]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
130\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
forkhead box p4; fork head-related protein like a; winged-helix repressor foxp4. [source:refseq;acc:nm\_138457]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2234.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2978.53\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33287\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen d2 (mage-d2 antigen) (breast cancer associated gene 1 protein) (bcg-1) (11b6) (hepatocellular carcinoma associated protein jcl-1). [source:swissprot;acc:q9unf1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
131\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
forkhead box protein p1 (hspc215). [source:swissprot;acc:q9h334]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2234.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2978.57\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33285\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
trophinin. [source:swissprot;acc:q12816]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
132\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dual specificity mitogen-activated protein kinase kinase 4 (ec 2.7.1.-) (map kinase kinase 4) (jnk activating kinase 1) (c-jun n- terminal kinase kinase 1) (jnkk) (sapk/erk kinase 1) (sek1). [source:swissprot;acc:p45985]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5948.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5441.83\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09318\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
forkhead box protein p3 (zinc finger protein jm2) (scurfin). [source:swissprot;acc:q9bzs1]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
2236.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2980.35\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33253\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
133\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
gaba(a) receptor-associated protein; gaba(a)-receptor-associated protein. [source:refseq;acc:nm\_007278]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
23421.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17580.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33225\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein s6 kinase-like 1. [source:refseq;acc:nm\_031464]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7013\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7662.77\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09265\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
134\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ba127l20.1 (novel glutathione-s-transferase). [source:sptrembl;acc:q9h4y5]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6670.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7286.66\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09242\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
gaba-a receptor-associated protein. [source:sptrembl;acc:q9by60]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
21785.2\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
16426.1\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.32626\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
135\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
apg3p; pc3-96 protein. [source:refseq;acc:nm\_022488]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
high-mobility group 20a. [source:refseq;acc:nm\_018200]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7248.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7916.96\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09226\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
136\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear transcription factor y subunit gamma (nf-y protein chain c) (nuclear factor yc) (nf-yc) (ccaat-binding transcription factor subunit c) (cbf-c) (transactivator hsm-1/2). [source:swissprot;acc:q13952]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3620.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4763.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.31556\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein s6 kinase, 52kda, polypeptide 1; ribosomal protein s6 kinase, 52kd, polypeptide 1. [source:refseq;acc:nm\_012424]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7020.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7667.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09214\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
137\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ccaat-binding transcription factor subunit b (cbf-b) (nf-y protein chain a) (nf-ya) (caat-box dna binding protein subunit a). [source:swissprot;acc:p23511]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3620.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4763.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.31556\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
t-box transcription factor tbx19 (t-box protein 19). [source:swissprot;acc:o60806]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6139.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6699.58\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09121\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
138\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutathione transferase omega 1 (ec 2.5.1.18) (gsto 1-1). [source:swissprot;acc:p78417]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6709\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7313.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09008\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
kv channel interacting protein 1; vesicle apc-binding protein; a-type potassium channel modulatory protein 1. [source:refseq;acc:nm\_014592]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2755.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2094.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.31555\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
139\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l37a. [source:swissprot;acc:p12751]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5762.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6277.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08946\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
potassium channel-interacting protein 4 isoform 4; calsenilin-like protein. [source:refseq;acc:nm\_147183]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
2759.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2099.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.31442\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
140\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
kv channel interacting protein 2 isoform 4; a-type potassium channel modulatory protein 2; cardiac voltage gated potassium channel modulatory subunit. [source:refseq;acc:nm\_173193]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
2760.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2100.27\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.31425\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-activating enzyme e1c (uba3 homolog, yeast); ubiquitin-activating enzyme e1c (homologous to yeast uba3). [source:refseq;acc:nm\_003968]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7628.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8310.74\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08944\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
141\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
brachyury protein (t protein). [source:swissprot;acc:o15178]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6171.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6720.84\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08897\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein sm d2 (snrnp core protein d2) (sm-d2). [source:swissprot;acc:p43330]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4405.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5782.08\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.3125\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
142\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
metalloprotease 1; metalloprotease 1 (pitrilysin family). [source:refseq;acc:nm\_014889]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
9276.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7090.37\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.30832\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ornithine carbamoyltransferase, mitochondrial precursor (ec 2.1.3.3) (otcase) (ornithine transcarbamylase). [source:swissprot;acc:p00480]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
10803\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11757.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08837\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
143\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
3-hydroxyanthranilate 3,4-dioxygenase (ec 1.13.11.6) (3-hao) (3-hydroxyanthranilic acid dioxygenase) (3-hydroxyanthranilate oxygenase). [source:swissprot;acc:p46952]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
10696.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11639.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08815\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
beta-1,4 mannosyltransferase. [source:refseq;acc:nm\_019109]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9275.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7089.65\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.30826\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
144\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-arrestin 2 (arrestin, beta 2). [source:swissprot;acc:p32121]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7692.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8370.25\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08814\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sad1/unc-84 protein-like 1. [source:swissprot;acc:o94901]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3349.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4362.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.30231\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
145\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-arrestin 1 (arrestin, beta 1). [source:swissprot;acc:p49407]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7693.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8366.42\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08741\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin activating enzyme e1-like protein. [source:refseq;acc:nm\_006395]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
16771.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12889.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.30122\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
146\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
associated molecule with the sh3 domain of stam (amsh) like protein. [source:refseq;acc:nm\_020799]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
11068\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8508.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.30082\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 3 (ec 2.7.1.33) (pantothenic acid kinase 3) (hpank3). [source:swissprot;acc:q9h999]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
10685.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11612.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08679\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
147\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 2, mitochondrial precursor (ec 2.7.1.33) (pantothenic acid kinase 2) (hpank2). [source:swissprot;acc:q9bz23]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
10684.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11611.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08677\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative breast adenocarcinoma marker (32kd). [source:refseq;acc:nm\_014453]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
11068\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
8508.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.30082\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
148\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
associated molecule with the sh3 domain of stam. [source:refseq;acc:nm\_006463]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
defender against cell death 1 (dad-1). [source:swissprot;acc:p46966]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6893.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7491.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08675\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
149\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuroendocrine differentiation factor; comparative gene identification transcript 149. [source:refseq;acc:nm\_016079]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11068\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8508.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.30082\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 1 (ec 2.7.1.33) (pantothenic acid kinase 1) (hpank1) (hpank). [source:swissprot;acc:q8te04]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10665\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11587.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08647\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
150\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein hspc134 (protein cda04). [source:swissprot;acc:q9by43]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11068\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8508.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.30082\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase plk (ec 2.7.1.-) (plk-1) (serine- threonine protein kinase 13) (stpk13). [source:swissprot;acc:p53350]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7136.14\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
7751.87\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.08628\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
151\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cathepsin z precursor (ec 3.4.22.-) (cathepsin x) (cathepsin p). [source:swissprot;acc:q9ubr2]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sh2 domain containing 3c; novel sh2-containing protein 3; sh2 domain-containing 3c; likely ortholog of mouse cas/hef1-associated signal transducer. [source:refseq;acc:nm\_005489]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4578.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5939.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.29746\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
152\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma antigen, family d, 4 isoform 1; mage1 protein; mage-e1 protein; maged4 protein. [source:refseq;acc:nm\_030801]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.29736\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nipsnap2 protein (glioblastoma amplified sequence). [source:swissprot;acc:o75323]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5538.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6016.13\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08627\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
153\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocellular carcinoma-associated protein hca3. [source:refseq;acc:nm\_138703]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.29736\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nipsnap1 protein. [source:swissprot;acc:q9bpw8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5544.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6022.42\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08611\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
154\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 3 (mage-3 antigen) (antigen mz2-d). [source:swissprot;acc:p43357]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.29736\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/